Sherman Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$788K Sell
657
-208
-24% -$213K 0.61% 27
2026
Q1
$796K Hold
865
0.73% 26
2025
Q4
$930K Hold
865
0.79% 25
2025
Q3
$660K Hold
865
0.57% 30
2025
Q2
$675K Hold
865
0.6% 30
2025
Q1
$715K Sell
865
-5,150
-86% -$4.29M 0.68% 27
2024
Q4
$4.64M Buy
+6,015
New +$4.98M 4.25% 5

Other funds holding LLY

Sherman Asset Management's LLY Position: Q2 2026 in Review

Sherman Asset Management reduced its Eli Lilly (LLY) stake by 24% in Q2 2026, selling an estimated $213K and leaving 657 shares worth $788K. The position accounts for 0.61% of the portfolio, ranked #27.

Sherman Asset Management first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.64M in Q4 2024. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Sherman Asset Management held 657 shares of Eli Lilly worth $788K as of Q2 2026.
  • Sherman Asset Management sold 208 Eli Lilly shares in Q2 2026, an estimated $213K.
  • Eli Lilly made up 0.61% of Sherman Asset Management's portfolio in Q2 2026, its #27 holding.
  • Sherman Asset Management first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • Sherman Asset Management's Eli Lilly position peaked at $4.64M in Q4 2024.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Sherman Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.